Tetraphenylphosphonium

Tetraphenylphosphonium

SCHEMBL6507702

O=S(=O)([O-])O[O-].c1ccc([P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1.c1ccc([P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.33
CA2 P00918 6/20 0.32
CA9 Q16790 6/20 0.32
CA12 O43570 5/20 0.32
SOS1 Q07889 1/20 0.32
CA1 P00915 4/20 0.32
HIF1A Q16665 1/20 0.32
CA7 P43166 2/20 0.31
ALDH1A1 P00352 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CA3 P07451 1/20 0.31
CA4 P22748 1/20 0.31
CA6 P23280 1/20 0.31
CA5A P35218 1/20 0.31
PLA2G7 Q13093 1/20 0.31
CA13 Q8N1Q1 1/20 0.31
CA14 Q9ULX7 1/20 0.31
CA5B Q9Y2D0 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetraphenylphosphonium SCHEMBL11324663 0.86 HTR6 (0.33) HTR6CA2CA9CA12SOS1
Tetraphenylphosphonium SCHEMBL3821606 0.85 HTR6 (0.39) HTR6CA2CA9CA12CA1
SCHEMBL11325583 0.84 TSHR (0.41) CA2CA9CA12CA1TSHR
Tetraphenylphosphonium SCHEMBL1271289 0.83 HTR6 (0.38) HTR6CA2CA9CA12CA1
Tetraphenylphosphonium SCHEMBL19615045 0.81 KEAP1 (0.39) HTR6CA2CA9CA12HIF1A
Tetraphenylphosphonium SCHEMBL1271290 0.81 TSHR (0.44) HTR6CA2CA9CA12CA1
SCHEMBL30892253 0.77 SNCA (0.47) CA2CA9CA1HIF1AALDH1A1
Tetraphenylphosphonium SCHEMBL21957774 0.76 GPR3 (0.50) CA2CA9CA1CA5APTPN1
Tetraphenylphosphonium SCHEMBL4930284 0.74 PTGS2 (0.47) CA2CA9CA1HIF1A
Tetraphenylphosphonium SCHEMBL29362652 0.74 HIF1A (0.50) CA2CA9CA12CA1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796474-B1 Macrolide compounds and methods and intermediates useful for their preparation RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-08-05 US disclosed
US-8796269-B2 Crystalline 2-(3,5-Bis(trifluoromethyl)phenyl)-N-(4-(4-fluoro-2-methylphenyl)-6-((7S,9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)pyridin-3-yl)-N,2-dimethyl-propanamide of the formula (I), their use in therapy, and process for the preparation of the same NERRE THERAPEUTICS LIMITED (GB) 2014-08-05 US disclosed
WO-2005056543-A2 PROCESS FOR USE IN THE PREPARATION OF OXIRANES FROM ALKENES, AND CATALYSTS FOR USE THEREIN AVECIA PHARMACEUTICALS LIMITED (GB) 2005-06-23 WO disclosed
US-4247620-A TETRAARYL PHOSPHONIUM, AMMONIUM OR ARSONIUM METAL POLYCARBOXYLATES KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1981-01-27 US disclosed